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Large Scale Matrix Degradation by Stromal Cells Independent of Invadopodia 
Abstract 
Invadopodia are actin-rich structures at the base of many neoplastic cells that sequester matrix 
metalloproteases that act to degrade the surrounding stroma to facilitate the invasive process. 
Conventional invadopodia are dependent upon Src kinase and the large GTPase dynamin 2 (Dyn 2). 
Whether invadopodia are the only mechanism by which cells degrade matrix is unclear. We have observed 
that cells of mesenchymal origin degrade matrix in an unique way different from tumor cells. The 
HYPOTHESIS of this study is that fibroblasts, and other cells of mesenchymal origin, degrade matrix by a 
mechanism distinct from that of epithelial-based tumor cells. The CONCLUSION is that stromal cells 
degrade matrix by a novel mechanism distinct from traditional invadopodia. 
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Figure 6. Matrix Degradation by Epithelial Cells and 
Fibroblasts Exhibits Distinct Requirements for Src Kinase   
Figure 5. Knockdown of Dyn 2 Induces a Modest  
Retention of MT1-MMP on the Cell Surface  
 
  
Invadopodia are actin-rich structures at the base of many neoplastic cells that  
sequester matrix metalloproteases that act to degrade the surrounding stroma  
to facilitate the invasive process.  Conventional invadopodia are dependent upon  
Src kinase and the large GTPase dynamin 2 (Dyn 2).  Whether invadopodia are  
the only mechanism by which cells degrade matrix is unclear.  We have observed  
that cells of mesenchymal origin degrade matrix in an unique way different from  
tumor cells.    
  
  
The HYPOTHESIS of this study is that fibroblasts, and other cells of  
mesenchymal origin, degrade matrix by a mechanism distinct from that  
of epithelial-based tumor cells. 
  
  
The GOALS of this study were to define the mechanisms supporting  
this novel form of matrix remodeling by: 
  
- Defining the requirements of Dyn 2 and Src kinase in matrix degradation by  
  fibroblasts and tumors of epithelial origin. 
  
- Testing the role of Dyn 2 depletion on MT1-MMP accumulation by cells both  
   internally and at the plasma membrane. 
  
 
Background and Goals 
Figure 1. Tumor Cells and Stromal Cells Exhibit Distinct  
Patterns of Matrix Degradation  
A variety of different tumor and mesenchymal cell types plated on fluorescent gelatin and  
cultured for 8h prior to fixation. (a,b) The pancreatic tumor cells BxPC3 and DanG show  
largely invadopodial-like (white arrowheads) and focal adhesion-like (arrows) degradation  
patterns. (c) The fibrosarcoma cell line HT1080 exhibits focal adhesion-like degradations and  
a unique pattern of centrally positioned degradation structure in a labyrinth or reticular-like  
display. (d-f) Mesenchymal cells exhibit a unique pattern of matrix degradation, whether they  
be rat fibroblasts, human fibroblasts, or pancreatic stellate cells. (g) Graph depicting the  
percentage of each cell type that degrades matrix after 8 hours. 
Figure 2. Reduction of Dynamin 2 (Dyn 2 ) Induces a  
Differential Response in Matrix Degradation Between  
Fibroblasts and Epithelial Cells  
 
Figure 3. Tamoxifen-Induced Knockout of Dyn 2 in 
MEFs Induces a Substantial Increase of Matrix 
Degradation Compared to Controls  
To examine another fibroblast cell line from a Dyn 2 genetic knockout model (kindly  
provided by Ferguson and De Camilli, Yale), matrix degradation was analyzed in MEFs  
from these knockout mice in the presence and absence of tamoxifen. (a,b) Immunostaining  
of control or tamoxifen-treated cells (4-5 days) stained for Dyn 2, or revealing matrix  
degradation on a fluorescent gelatin substrate. Control cells show substantial amounts of  
endogenous cytoplasmic Dyn 2 but exhibit almost no matrix degradation. In contrast, cells  
in which Dyn 2 has been reduced exhibit a 6-7-fold increase in matrix degradation with a  
characteristic reticular network pattern. (d) Western blot analysis of cells +/- tamoxifen  
treatment blotted for Dyn 2. (e-g) Re-expression of either Dyn 1 or Dyn 2 in tamoxifen- 
induced Dyn 2 knockout MEFs results in a reversal of the degradation phenotype (reduced  
degradation). Fluorescence images showing re-expression of either of the neuronal-specific  
Dyn 1 or ubiquitously expressed Dyn 2 with corresponding degradation patterns on  
fluorescent gelatin. Note that the surrounding cells in which dynamin is not expressed  
degrade large amounts of matrix in comparison to the rescued cells (*) that degrade no  
matrix at all. (g) Quantitation of the effect of dynamin knockout on matrix degradation  
by MEFs. Note the substantial increase in the tamoxifen-treated Dyn KO cells, which is  
markedly reduced by expression of wild type Dyn 2 and Dyn 1-GFP. In contrast, the  
Dyn 2K44A mutant-expressing cells continue to degrade large amounts of matrix.   
Western blot analysis of six different mesenchymal and epithelial cell lines in which  
endogenous Dyn 2 levels have been experimentally reduced, followed by SDS-PAGE  
and Western blot analysis with antibodies to MT1-MMP. (b) Quantitation of three  
distinct experiments shows a modest accumulation of MT1-MMP protein upon Dyn 2  
knockdown. While levels were increased by nearly 50% in the RF, DKO MEFS, and  
BxPC3 cells, there was only a modest incease observed in the PSC cells and an actual  
loss of protease in the DanG cells.  
Figure 4. A Reduction of Dyn 2 Causes Accumulation  
of MT1-MMP  
Conclusions 




In this study we have found that: 
 
 
•  Fibroblasts and cells of mesenchymal origin degrade matrix but appear  
   to do so by a mechanism distinct from epithelial-based tumor cells. 
  
•  Matrix degradation in fibroblasts appears to be mediated by focal  
   adhesion sites or at a reticular structure at the cell base.  Epithelial  
   tumor cells degrade by both focal adhesions and traditional invadopodia. 
  
•  Matrix degradation by invadopodia in epithelial tumor cells is markedly  
   reduced by Dyn2 knockdown or inhibition of Src kinase while degradation  
   by fibroblasts is increased substantially by Dyn 2 depletion and is Src  
   independent.  
  
•  Reduction in Dyn2 levels results in a 2 fold increase of MT1-MMP with  
   a modest proportion of this protease remaining at the cell surface.  (a,c) Western blot analysis of cell homogenates of either rat fibroblasts treated with  
siRNA to knockdown dynamin, or MEFs treated with tamoxifen to induce the Dyn 2 knockout.  
Following reduction of Dyn 2 levels, cells were incubated in biotin to label all cell surface  
proteins, then homogenized followed by a pull-down with streptavidin beads, then SDS-PAGE  
and Western blot (see cartoon for experimental sequence). (b,d) Graphs represent   
quantitation of three different experiments showing both total, and surface populations of  
MT1-MMP from cells both before and after Dyn2 knockdown. As shown before in Fig. 4, total  
MT1 levels were increased by 2 fold, although changes in the levels of MT1 residing at the  
cell surface remain only modestly increased (20-40%) following Dyn2 knockdown.  This minor  
increase suggests that the massive increase in matrix degradation by the mesenchymal cells  
following Dyn2 reduction may not be dependent upon an accumulation of active protease at  
the cell surface.  
Assessing the effects of Dyn2 knockdown on matrix degradation in six different fibroblast  
and epithelial cell types. Cells were treated with siRNA to reduce Dyn2 levels over 72 h, then  
trypsinized, resuspended, and plated on fluorescent gelatin-coated coverslips for six hours  
in the presence of the protease inhibitor BB94. Cells were then rinsed and allowed to degrade  
for 8 hrs prior to fixation. (a-e) A variety of mesenchymal fibroblastic cells that normally  
exhibit modest amounts of degradation show increased matrix remodeling by 4-5-fold upon  
reduction of Dyn 2. While some focal adhesion-like degradation (white arrows) is observed,  
most of it is a reticular-like degradative pattern at the center of the cell. In contrast,  
pancreatic epithelial tumor cells that spontaneously degrade via invadopodia are markedly  
inhibited in their degradative capacity by Dyn2 knockdown (g-i). (j) Western blot analysis of  
cell homogenates showing near complete elimination of Dyn2 expression in the six cell types  
examined.     
siRNA 
Invadopodia function is dependent upon Src kinase. To determine if the distinct matrix  
degradation processes observed in the different cell types shared a requirement for Src  
kinase, we treated cells with the Src inhibitor PP2. Cells were plated on gelatin in the presence  
of the MMP inhibitor BB94 for 5 hours during plating to prevent degradation during attachment.   
Subsequently cells were washed free of BB94 and incubated in 25mM PP2 for 13 hours. (a, e)  
The pancreatic cancer lines DanG and BxPC3 both show robust degradation under control  
conditions, but are almost completely inhibited when treated with 25mM PP2 (b, f). By contrast,  
the fibrosarcoma cell line HT108 (c, d) and the Dyn2 knockout fibroblast cell line DKO (g, h)  
both continue to degrade large amounts of matrix even under these high concentrations of  
inhibitor.  (i) A graph depicting the percentage of cells that degrade matrix upon Src inhibition.  
Note the graphic contrast in drug sensitivity between the epithelial tumor cells and the  
fibroblasts/fibroscarcoma cell lines. 
